BioDlink
Manufacturing · China · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
no.120 Chang Yang Street Suzhou Industri...Phone Number
+86 51262965186Website
www.biodlink.comRevenue
$150 MillionStock Symbol
1875Industry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About BioDlink
BioDlink (Stock Code: 1875.HK) is dedicated to becoming the industry leading and trusted biopharmaceutical best partner for global clients. With extensive practical experience, mature technical platforms and robust quality system, BioDlink has developed diversified strategic partnerships with domestic and international pharmaceutical companies to provide one-stop CDMO solutions for drug development and manufacturing, which help customers to accelerate the development and manufacturing of biologics, especially antibody-drug conjugates (ADCs), empowering to achieve high-quality development for the industry.Explore more
BioDlink Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BioDlink your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on BioDlink recently announced quarterly report
Check out if BioDlink is spiking on competitors!
Click to see if BioDlink had a recent Job posting/layoffs
Product Launch: Get notified when BioDlink launches new products
Congratulate Masked Content for being promoted to Masked Content at BioDlink
Check if BioDlink has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
BioDlink, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once BioDlink has new funding data
Recommended Actions
Reach out to Masked Content who joined BioDlink as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
BioDlink is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
BioDlink is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BioDlink.
BioDlink Tech Stack
A closer look at the technologies used by BioDlink
Most Recent Scoops
Event
Events, Engineering, Sales, Bioengineering, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Event
Events, Engineering, Sales, Bioengineering, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Award
Award
Event
Events, Engineering, Research & Development, Training, Machine Learning, Learning & Development, Search, Laboratory Operations, Medical Education & Training, Medical Research, Chemical Engineering, Artificial Intelligence, Clinical Operations, Healthcare Technology, HR Operations, Operations
BioDlink News & Media
BioDlink Named "Emerging CDMO of the Year" at the 2026 Asia-Pacific Biopharma Excellence Awards
BioDlink has been named "Emerging CDMO of the Year" for its innovation in complex biologics and ADC development. The award recognizes its proprietary technology platforms, scalable manufacturing, and a proven quality system with over 100 audits completed. SUZHOU, China, March 13, 2026 /PRNewswire/ -- BioDlink, an innovation-driven Contract Development and Manufacturing Organization (CDMO), today announced that it has been named "Emerging CDMO of the Year" at the Asia-Pacific Biopharma ExcellenceBioDlink Named "Emerging CDMO of the Year" at the 2026 Asia-Pacific Biopharma Excellence Awards
BioDlink has been named "Emerging CDMO of the Year" for its innovation in complex biologics and ADC development. The award recognizes its proprietary technology platforms, scalable manufacturing, and a proven quality system with over 100 audits completed. SUZHOU, China, March 13, 2026...BioDlink Recognized by Client for Enabling the World's First Dual-Payload ADC to Enter Clinical Trials
BioDlink received a formal letter of appreciation from Chengdu Kanghong Pharmaceutical Group for its contribution to advancing KH815, the world's first dual-payload antibody–drug conjugate (ADC) to enter clinical development. BioDlink enabled IND approval 1.5 months ahead of schedule through efficient process development, manufacturing, and analytical execution. SUZHOU, China, Feb. 9, 2026 /PRNewswire/ -- BioDlink announced that it has received a formal letter of appreciation from its client, ChBioDlink Modernizes Quality Management with Successful Go-Live of Veeva QMS
BioDlink has successfully implemented Veeva QMS, marking a key milestone in its digital transformation and strengthening its GMP quality management capabilities. It enables a standardized, data-driven quality framework, supporting compliance, efficiency, and long-term continuous improvement for global partners. SUZHOU, China, Feb. 3, 2026 /PRNewswire/ -- BioDlink today announced the successful go-live of Veeva QMS, marking a key milestone in the company's quality digitalization strategy. The sys
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BioDlink
Sign Up For FreeTo access detailed company insights
BioDlink (Stock Code: 1875.HK) is dedicated to becoming the industry leading and trusted biopharmaceutical best partner for global clients. With extensive practical experience, mature technical platforms and robust quality system, BioDlink has developed diversified strategic partnerships with domestic and international pharmaceutical companies to p... Read More
